These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15222278)

  • 1. Role of heparin in the antithrombotic treatment of valvulopathies.
    Hanania G
    J Heart Valve Dis; 2004 May; 13(3):339-43. PubMed ID: 15222278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option.
    McLintock C
    Thromb Res; 2011 Feb; 127 Suppl 3():S56-60. PubMed ID: 21262443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulation of pregnant women with mechanical heart valve prostheses].
    Lindhoff-Last E; Schinzel H; Erbe M; Schächinger V; Bauersachs R
    Z Kardiol; 2001; 90 Suppl 6():125-30. PubMed ID: 11826815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heart disease, anticoagulants and pregnancy].
    Salazar E; Izaguirre R
    Rev Esp Cardiol; 2001; 54 Suppl 1():8-16. PubMed ID: 11535183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant choices in pregnant women with mechanical heart valves: balancing maternal and fetal risks--the difference the dose makes.
    McLintock C
    Thromb Res; 2013 Jan; 131 Suppl 1():S8-10. PubMed ID: 23452748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulation in mechanical valve prostheses. A difficult situation].
    Roudaut R; Roudaut MF; Labèque JN; Perron JM; Lafitte S; Jaïs C; Zabsonré P; Coste P
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1285-90. PubMed ID: 11794971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The obstetrical patient with a prosthetic heart valve.
    Danik S; Fuster V
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):481-91. PubMed ID: 16962923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulant therapy during pregnancy in patients with mechanical valvular prostheses].
    Hanania G; Nassivera L
    Arch Mal Coeur Vaiss; 2001 Oct; 94(10):1073-6. PubMed ID: 11725712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy and anticoagulant therapy. Indications and strategies].
    Almange C; Schleich JM; Laurent M
    Arch Mal Coeur Vaiss; 2000 May; 93(5):613-8. PubMed ID: 10858859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.
    Abildgaard U; Sandset PM; Hammerstrøm J; Gjestvang FT; Tveit A
    Thromb Res; 2009 Jul; 124(3):262-7. PubMed ID: 19162303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation management of valve replacement patients.
    Ezekowitz MD
    J Heart Valve Dis; 2002 Jan; 11 Suppl 1():S56-60. PubMed ID: 11843522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early anticoagulation after mechanical valve implantation, and related complications.
    Puri D; Kumar A; Basu R; Chaudhary A; Sarwal V; Sahoo M; Mahant TS
    J Heart Valve Dis; 2008 Jul; 17(4):418-24; discussion 425. PubMed ID: 18751472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin use during pregnancy.
    Houman MH; Ksontini-Smida I; Miled M
    Tunis Med; 2002 Jun; 80(6):297-305. PubMed ID: 12534039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant therapy in pregnant women with mechanical heart valves.
    Leyh RT; Fischer S; Ruhparwar A; Haverich A
    Arch Gynecol Obstet; 2003 Apr; 268(1):1-4. PubMed ID: 12673466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.